Learning Objectives:

1.Analyze the data studying stenting for vulnerable plaques

2.Critically analyze and describe the strengths, limitations of the PREVENT trial

Session date: 
05/03/2024 - 7:30am to 8:30am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dr. Mina Kerolos